Furthermore, other drugs used for the treatment of hematological diseases such as multiple myeloma in combination with other drugs are known NF-κB inhibitors such as the agonistic derivative of glucocorticoid hormones (corticosteroids) prednisone, or dexamethasone. Here, NFKB1 is linked to AL amyloidosis.